Print Bookmark Email

Infectious Diseases


The division provides world-class therapies and diagnostic services.


Kwang Sik Kim, M.D., leads a division committed to translational research.

About Us
The Eudowood Division of Pediatric Infectious Diseases at Johns Hopkins, treats all aspects of infectious diseases and studies pathogens, prevention, transmission and therapy of many of diseases, including bacteria, mycobacteria, parasites and viruses. Its faculty are experts on a wide range of infectious agents, from the viruses and bacteria that cause common respiratory tract infections to the more serious illnesses caused by the Human Immunodeficiency Virus (HIV).

A wide variety of interdisciplinary research projects examine some of the more exciting issues in infectious disease, such as antibiotic resistance, emerging infections, and the production of safe and effective vaccines.The Latest Vaccine News from the AAP. 

We are nationally-recognized experts in our fields. Recent honors and awards.

In keeping with his vision that an infectious disease division should embrace many academic fields, Director Kwang Sik Kim, M.D., created a monthly ID meeting designed to help scientists from all Johns Hopkins research divisions come together and collaborate on new infectious disease research projects.

Our research and clinical experts are often sought for comment on the national stage on issues ranging from influenza and H1N1 to vaccine safety and preventionn of respiratory virus and other pathogens in a hospital setting. Here at Hopkins Children's, they work closely with counterparts in adult care at Johns Hopkins Hospital in preventing hospital-acquired infections and antibiotic resistance. To prevent the latter among pediatric patients, they helped design and now oversee an Web-based approval system of restricted antimicobials. Read more about the division's antibiotic approval system. 

Our Clinical Expertise

Adenovirus (See "Viral Infections)
Bone and Joint Infections
Central Nervous System Infections
Deep-Seated Fungal Infections
Fever of Unknown Origin
Infections in Immunocompromised Patients
Infections in Neonates
Infections in Sickle Cell
Intra-Abdominal Infection
Intravascular Device-Related Infections
Intravascular Infections such as Endocarditis
Herpes (See "Viral Infections)
Opportunistic Infections
Parasitic Infections such as Malaria
Post-Op Wound Infections
Respiratory Tract Infections
Sepsis and Bloodstream Infection
Skin/Skin Structure Infections
Straphylococcal Infections including MRSA, Toxic Shock
Travel-Related Infections
Tuberculosis (TB)
Urinary Tract Infections
Vaccine-Related Disorders
Viral Infections, such as Adenovirus, Herpes
V-P Shunt Infection


An Historic Fight Against Infectious Disease

Neal HalseyFaculty in the Eudowood Division of Pediatric Infectious Diseases at Hopkins Children's have been frequently in the news recently, commenting on multiple aspects of this year's H1N1 virus as well as the safety of the vaccine to prevent it. The efforts here at Johns Hopkins and around the globe to protect children from exposure to H1N1, and to partner with parents and community healthcare providers to care for those who contract it, will become another chapter in the historic and ongoing fight, at Johns Hopkins, against pediatric infectious diseases. Ironically, the very vaccines developed to conquer their microbes, are now the ones under the microscope. Learn More About An Historic Fight Against Infectious Disease

Hopkins-Designed Animal TB “Tracker” To Speed Drug and Vaccine Studies

TB TrackerJohns Hopkins researchers have developed a novel way to monitor in real time the behavior of the TB bacterium in mouse lungs noninvasively pinpointing the exact location of Mycobacterium tuberculosis. The new monitoring system is expected to speed up what is currently a slow and cumbersome process to test the safety and efficacy of various TB drug regimens and vaccines in animals. Plans are already under way for developing a similar system to monitor TB disease in humans. Learn More About Hopkins-Designed Animal TB “Tracker” To Speed Drug and Vaccine Studies